Lunai Bioworks (LNAI) Operating Expenses (2011 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Operating Expenses of $1.4 million in Q1 2026, down 20.58% quarter-over-quarter from $1.8 million in Q4 2025, and down 65.21% on a YoY basis from $4.2 million in Q1 2025.
Lunai Bioworks (LNAI) Operating Expenses (2011 - 2026) Analysis & Trends
Lunai Bioworks' Operating Expenses history runs 16 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 65.21% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $133.5 million (up 68.66% YoY), while the FY2025 annual figure was $189.0 million, up 131.46% from the prior year.
- Operating Expenses was $1.4 million for Q1 2026 at Lunai Bioworks, down from $1.8 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $126.9 million in Q2 2025 to a low of $1.4 million in Q1 2026.
- Historically, Operating Expenses has averaged $24.6 million across 5 years, with a median of $4.5 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Operating Expenses jumped 1164.47% in 2024, then sank 93.8% in 2025.
- A 5-year view of Operating Expenses shows it stood at $4.4 million in 2022, then decreased by 2.24% to $4.3 million in 2023, then increased by 6.47% to $4.5 million in 2024, then sank by 59.89% to $1.8 million in 2025, then dropped by 20.58% to $1.4 million in 2026.
- The last three Operating Expenses figures came in at $1.4 million (Q1 2026), $1.8 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 1.82 Mn |
| Sep 30, 2025 | 3.31 Mn |
| Jun 30, 2025 | 126.92 Mn |
| Mar 31, 2025 | 4.16 Mn |
| Dec 31, 2024 | 4.55 Mn |
| Sep 30, 2024 | 53.34 Mn |
| Jun 30, 2024 | 17.10 Mn |
| Mar 31, 2024 | 51.38 Mn |
| Dec 31, 2023 | 4.27 Mn |
| Sep 30, 2023 | 8.88 Mn |
| Jun 30, 2023 | 22.93 Mn |
| Mar 31, 2023 | 4.06 Mn |
| Dec 31, 2022 | 4.37 Mn |
| Sep 30, 2022 | 7.19 Mn |
| Jun 30, 2022 | 98.21 Mn |
| Mar 31, 2022 | 4.03 Mn |
| Dec 31, 2021 | 6.33 Mn |
| Sep 30, 2021 | 7.50 Mn |
| Jun 30, 2021 | 14.18 Mn |